300677 英科医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.4955.6698.7672.4063.972
总资产报酬率 ROA (%)2.0592.7054.7501.5772.988
投入资产回报率 ROIC (%)2.1952.8554.9971.6863.272

边际利润分析
销售毛利率 (%)37.81824.12223.63613.69813.126
营业利润率 (%)15.86612.39417.6086.34510.693
息税前利润/营业总收入 (%)22.16616.58612.3101.9711.167
净利润/营业总收入 (%)13.08910.55015.6645.6099.667

收益指标分析
经营活动净收益/利润总额(%)121.60239.99788.07937.29879.851
价值变动净收益/利润总额(%)-23.88356.77821.31559.39520.292
营业外收支净额/利润总额(%)-2.242-0.035-4.2210.864-0.393

偿债能力分析
流动比率 (X)0.9810.8501.4951.8113.244
速动比率 (X)0.8760.7811.4091.6772.926
资产负债率 (%)52.99453.67548.94239.82725.278
带息债务/全部投入资本 (%)45.68746.53440.98729.2499.046
股东权益/带息债务 (%)107.872103.904128.476213.992881.510
股东权益/负债合计 (%)86.93184.828102.684148.621291.120
利息保障倍数 (X)3.3353.952-2.685-0.445-0.123

营运能力分析
应收账款周转天数 (天)35.75649.40043.19338.40036.158
存货周转天数 (天)70.81061.95859.78564.93165.252